Instrument Inactif

Communiqués Auxilium Pharmaceuticals, Inc.

Actions

US05334D1072

Produits pharmaceutiques

Cours en clôture Nasdaq
- ^USD	-

09/10/14	Auxilium Pharmaceuticals : accepte l'offre d'Endo et renonce à QLT	RE
09/10/14	Alcoa : Wall Street ouvre en baisse sur des prises de bénéfices	RE

Communiqués

27/01/15	Auxilium Pharmaceuticals : Announces Results from Special Meeting of Stockholders	PR
22/12/14	Auxilium Pharmaceuticals : Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease	PR
11/12/14	Auxilium Pharmaceuticals : Announces Date for Special Meeting of Stockholders	PR
20/11/14	Auxilium Pharmaceuticals : Presents STENDRA Data At SMSNA Scientific Meeting	PR
20/11/14	Auxilium Pharmaceuticals : Presents XIAFLEX For Peyronie's Disease Data At SMSNA Scientific Meeting	PR
19/11/14	Auxilium Pharmaceuticals : Endo Announces Early Termination of HSR Act Waiting Period in Connection with its Proposed Acquisition of Auxilium Pharmaceuticals	PR
19/11/14	Auxilium Pharmaceuticals : Endo Announces Early Termination of HSR Act Waiting Period in Connection with its Proposed Acquisition of Auxilium Pharmaceuticals	PR
03/11/14	Auxilium Pharmaceuticals : to Present XIAFLEX and STENDRA Data at SMSNA Scientific Meeting	PR
20/10/14	Auxilium Pharmaceuticals : Announces XIAFLEX Now Approved For The Concurrent Treatment Of Up To Two Affected Joints In The Same Hand In Dupuytren's Contracture Patients	PR
14/10/14	Auxilium Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Auxilium Pharmaceuticals Inc.	PR
14/10/14	AUXILIUM PHARMACEUTICALS : INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Auxilium Pharmaceuticals, Inc.	PR
09/10/14	Auxilium Pharmaceuticals : Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion	PR
09/10/14	Auxilium Pharmaceuticals : Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion	PR
22/09/14	Auxilium Pharmaceuticals : Endo International Comments On Auxilium Pharmaceutical's Rejection Of Its Acquisition Proposal	PR
22/09/14	Auxilium Pharmaceuticals : Licensing Agreements, Results of Clinical Trials, and Acquisitions - Research Reports on Gilead, AbbVie, Pfizer, Auxilium and Endo	PR
22/09/14	Auxilium Pharmaceuticals : Provides Transaction Update	PR
18/09/14	Auxilium Pharmaceuticals : Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting	PU
17/09/14	Auxilium Pharmaceuticals : Responds To Unsolicited Proposal From Endo International	PR
16/09/14	Auxilium Pharmaceuticals : Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock	PR
09/09/14	Auxilium Pharmaceuticals : Announces Corporate Restructuring Designed To Streamline Operations, Maximize Cash Flow And Drive Sustainable Earnings Growth	PU
28/08/14	Auxilium Pharmaceuticals : To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting	PU
27/08/14	Auxilium Pharmaceuticals : To Present At The Morgan Stanley Healthcare Conference	PR
21/08/14	Auxilium Pharmaceuticals : Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite	PR
11/08/14	Auxilium Pharmaceuticals : Appoints Andrew Saik Chief Financial Officer	PU
07/08/14	Auxilium Pharmaceuticals : Announces Second Quarter 2014 Financial Results	PU